Tag: Eastern Vascular Society
New book penned by vascular icon charts career in surgery, revolutionary...
A new memoir penned by former Society for Vascular Surgery (SVS) President and vascular surgery leader Frank J. Veith, MD, which touches on...
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society...
EVS 2022: Weaving magic in academic vascular surgery at JVS
Past Journal of Vascular Surgery (JVS) group editor-in-chief Peter Gloviczki, MD, invoked his hobby of magic to help illustrate what it requires to take...
EVS 2022: New study shows ‘encouraging increase in academic footprint of...
How does vascular surgery compare to other specialties in the growth of gender diversity in published research? “Are we leaders in the field, or...
Eastern Vascular gathering challenged to forge next generation of evolution
Evolution was the core theme of the Presidential Address Robert Rhee, MD, delivered from the Eastern Vascular Society (EVS) annual meeting stage in Philadelphia...
Vascular Specialist–November 2022
In this issue:
First data from BEST-CLI are revealed at the American Heart Association (AHA) Scientific Sessions (p. 1 and 12–13)
The Society...
EVS 2022: Study suggests lower rates of aortic rupture, mortality after...
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the...
New study indicates cost-effectiveness of Denali IVC filter over Option device
Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter than with the Option IVC...
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to...
Vascular Specialist–December 2021
In this issue:
*This issue went to press before Congress moved to address cuts to Medicare due to kick in Jan. 1, 2022.
"Countdown to...
PTFE crural bypasses: ‘Very acceptable patency, excellent limb salvage is obtainable...
“The mantra I always use with fellows is bad vein, bad bypass.” Those were the words of Gregg Landis, MD, system chief of vascular...
‘Female sex predicts reintervention after elective EVAR for AAA’
Females were found to be at greater risk of reintervention following elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) at both the...
Vascular Specialist–November 2021
In this issue:
"In good hands?" The twin issues of center volumes for open AAA repair as well as training implications came under the...
The top 10 most popular Vascular Specialist stories in September
Five-year data from the ACST-2 trial comparing carotid endarterectomy and carotid artery stenting, a report from the Crawford Forum at the 2021 Vascular Annual...
Vascular Specialist–October 2021
In this issue:
"Not all cuts disappear": We take a look at the threat posed to vascular surgery—and the office-based lab (OBL) setting in...
Registry data show greater clot chronicity on post-procedure inspection than initially...
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
EVS 2021: Vascular surgery as ‘an enabling service’ for the wider...
Vascular surgery is as important as anesthesia in providing a safe operating room (OR), Richard Powell, MD, the vascular section chief at Dartmouth-Hitchcock Medical...
Endologix receives FDA Breakthrough Device designation for ChEVAS system
Endologix announced the company’s ChEVAS (chimney endovascular aneurysm sealing) system has been granted a Breakthrough Device designation from the Food and Drug Administration (FDA). The...
New analysis finds DCBs lead to greater four-year survival after fempop...
Patients treated with a paclitaxel-coated balloon saw greater survival, freedom from amputation and amputation-free survival through four-year follow-up after their initial femoropopliteal revascularization operation...
NYC study shows 50% limb salvage rate in COVID-19 patients with...
Data gathered from patients presenting with acute limb ischemia (ALI) during the peak of the COVID-19 pandemic at the heart of New York City—a...